Patrick Griffin soars in as ImmusanT CMO
This article was originally published in Scrip
Privately-held biotech ImmusanT has hired Dr Patrick Griffin chief medical officer and senior vice-president of development. Dr Griffin joins ImmusanT from Sanofi's immuno-inflammation therapeutic strategy unit where he was most recently head of external innovation. He originally joined Sanofi in 2005 as senior director of clinical development.
ImmusanT has also appointed Michelle Hipwood director of finance and operations. Ms Hipwood was most recently executive director and chief operating officer at The Capital Network.